Date: Thu, 18 Dec 1997 14:51:47 GMT
Server: Stronghold/1.3.4 Ben-SSL/1.3 Apache/1.1.3
Content-type: text/html
Content-length: 11778
Last-modified: Mon, 06 Oct 1997 14:23:13 GMT

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>
<HEAD>
<TITLE>Home</TITLE>
<META NAME="Author" CONTENT="Nancy Everett">
<META NAME="Generator" CONTENT="NetObjects Fusion 2.0.1 for Windows">

</HEAD>

<BODY BGCOLOR="#0000FF" LINK="#FFFFFF" VLINK="#FF80C0" TEXT="#FFFFFF">

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=56 HEIGHT =25><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =56 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=440><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =440 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=179><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =179 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =80></TD>
	<TD WIDTH=440 ALIGN="center" VALIGN="middle"><IMG HEIGHT=80 WIDTH=440 SRC="./assets/images/banner1_copy.JPG"  BORDER=0  ALT="Picture" ></TD>
	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=307 HEIGHT =5><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =307 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=338><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =338 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=30><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =30 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=338><P><FONT COLOR="#80FFFF" SIZE="+3" FACE="Ribbon131 BT">Pioneers in Natural Immunotherapy</FONT></TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=54 HEIGHT =7><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =54 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=386><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =386 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=235><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =235 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=386><P><FONT COLOR="#FF0080" SIZE="+1" FACE="Orator">Products Under Development</FONT></TD>

	<TD></TD>
   </TR>
  </TABLE>
<TABLE CELLPADDING=0 CELLSPACING=0 BORDER=0 WIDTH=675>
<TR VALIGN="top" ALIGN="left">
<TD>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=289>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=50 HEIGHT =17><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =50 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=239><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =239 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=239><P><A HREF="./html/product_chart.htm"><B><FONT COLOR="#80FFFF" FACE="Arial Narrow,Helvetica Condensed,C Helvetica Condensed">Multikine™</B></FONT></A><B><FONT COLOR="#80FFFF" FACE="Arial Narrow,Helvetica Condensed,C Helvetica Condensed"></B></FONT></P><P><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Clinical trials are in process for:</FONT>
<UL TYPE="SQUARE"><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Head and Neck Cancer</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Prostate Cancer</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">HIV Treatment</FONT></LI>
</UL><P><A HREF="./html/product_chart.htm"><B><FONT COLOR="#80FFFF" FACE="Arial Narrow,Helvetica Condensed,C Helvetica Condensed"><U>HGP-30</B></FONT></U></A><B><FONT COLOR="#80FFFF" FACE="Arial Narrow,Helvetica Condensed,C Helvetica Condensed"><U></B></FONT></U></P><P><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Clinical trials are in process for:</FONT>
<UL TYPE="SQUARE"><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">HIV Vaccine</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">HIV Treatment</FONT></LI>
</UL><P><A HREF="./html/product_chart.htm"><B><FONT COLOR="#80FFFF" FACE="Arial Narrow,Helvetica Condensed,C Helvetica Condensed">L.E.A.P.S.-Heteroconjugate</B></FONT></A><B><FONT COLOR="#80FFFF" FACE="Arial Narrow,Helvetica Condensed,C Helvetica Condensed"></B></FONT></P><P><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Preclinical trials are in process for:</FONT>
<UL TYPE="SQUARE"><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Tuberculosis (TB)</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">TB Diagnostic Kit</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Malaria</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">Herpes Simplex</FONT></LI><LI><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Futura Book">HIV</FONT></TD>

   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=2 HEIGHT =67></TD>
   </TR>
  </TABLE>
</TD>
<TD>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=386>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=15 HEIGHT =18><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =15 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=6><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =6 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=302><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =302 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=9><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =9 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=54><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =54 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=2 HEIGHT =420></TD>
	<TD WIDTH=311 COLSPAN=2><P><A HREF="./html/_shareholder_letter.htm"><B><FONT FACE="Orator">Letter to Shareholders</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/mission.htm"><B><FONT FACE="Orator">Mission Statement</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/basics.htm"><B><FONT FACE="Orator">Basics of the Immune System</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/questions.htm"><B><FONT FACE="Orator">Frequently Asked Questions</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/product_chart.htm"><B><FONT FACE="Orator">Products Under Development Chart</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="http://www.prnewswire.com/cgi-bin/liststory?445563^1"><B><FONT FACE="Orator">Press Releases</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/investor.htm"><B><FONT FACE="Orator">Investor Information</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/publications.htm"><B><FONT FACE="Orator">Scientific Publications</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/corporate.htm"><B><FONT FACE="Orator">Corporate Information</B></FONT></A><B><FONT FACE="Orator"></B></FONT></P><P><A HREF="./html/employment.htm"><B><FONT FACE="Orator">Employment Opportunities</B></FONT></A><B><FONT FACE="Orator"></B></FONT></TD>

	<TD></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=5 HEIGHT =12></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =60></TD>
	<TD WIDTH=308 COLSPAN=2><P><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Modern">Stock Exchange: American Stock Exchange<BR>Common Stock: HIV<BR>Warrants: HIV.WS</FONT></TD>

	<TD COLSPAN=2></TD>
   </TR>
  </TABLE>
</TD>
</TR>
</TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=80 HEIGHT =28><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =80 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=496><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =496 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=99><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =99 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=496><P><FONT COLOR="#FFFFFF" SIZE="-1">Except for historical information, any forward-looking statements contained in these materials, as indicated by language such as &quot;we expect&quot;, may involve risks and uncertainties including those associated with timely development of new products and other&nbsp; risks as set forth in our Form 10-Q filed with the Securities and Exchange Commission for the quarter ended June 30, 1996. Such statement represent our present judgment and actual results could differ materially. CEL-SCI Corporation disclaims any obligation to update forward-looking statements<BR></FONT>&nbsp;</TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=195 HEIGHT =21><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =195 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=242><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =242 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=238><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =238 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=242><P ALIGN="CENTER"><FONT COLOR="#C0C0C0" SIZE="-1" FACE="Futura Book">Site designed and hosted by </FONT><A HREF="http://everettcd.com"><FONT COLOR="#C0C0C0" SIZE="-1" FACE="Futura Book">everettcd.com</FONT></A><FONT COLOR="#C0C0C0" SIZE="-1" FACE="Futura Book"> and is protected by copyright law &copy;1997-10/5/97</FONT></TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=43 HEIGHT =17><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =43 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=520><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =520 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=112><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =112 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =66></TD>
	<TD WIDTH=520><P><FONT COLOR="#FFFFFF" SIZE="-2" FACE="Modern">Except for historical information, any forward-looking statements contained in these materials, as indicated by language such as &quot;we expect&quot;, may involve risks and uncertainties including those associated with timely development of new products and other risks as set forth in our Form 10-Q filed with the Securities and Exchange Commission for the quarter ended June 30, 1996. Such statement represent our present judgment and actual results could differ materially. CEL-SCI Corporation disclaims any obligation to update forward-looking statements</FONT></TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=675>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=123 HEIGHT =16><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =123 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=63><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =63 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=70><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =70 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=130><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =130 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=289><IMG SRC="./assets/auto_generated_images/img_39325fe5.gif" WIDTH =289 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =20></TD>
	<TD WIDTH=263 COLSPAN=3><P><A HREF="http://everettcd.com"><FONT COLOR="#FFFFFF" SIZE="-1" FACE="ITC Officina Sans Book">site design and hosted by everettcd.com</FONT></A><FONT COLOR="#FFFFFF" SIZE="-1" FACE="ITC Officina Sans Book"></FONT></TD>

	<TD></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=5 HEIGHT =14></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=2 HEIGHT =29></TD>
	<TD WIDTH=70 ALIGN="center" VALIGN="middle"><IMG HEIGHT=29 WIDTH=70 SRC="./assets/"  BORDER=0  ALT="Picture" ></TD>
	<TD COLSPAN=2></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=5 HEIGHT =515></TD>
   </TR>
  </TABLE>
</BODY>
</HTML>
